Therefore, while all 55 cases were used to construct a computational atlas of the MTL, clinical analyses were performed in a subset of 47 cases with an “AD continuum” diagnosis and no confounding non-AD tau (i.e., Pick’s disease, progressive supranuclear palsy, and corticobasal degeneration) or FTLD-TDP43 pathology. The gene discussed is MAPT; the disease is Pick disease.